These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 37817739)

  • 21. Service uptake and characteristics of injection drug users utilizing North America's first medically supervised safer injecting facility.
    Wood E; Tyndall MW; Qui Z; Zhang R; Montaner JS; Kerr T
    Am J Public Health; 2006 May; 96(5):770-3. PubMed ID: 16571703
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The initial experience in supervised injecting facilities in Denmark].
    Axelsson A; Hvam F; Bonde M; Olsen ML; Kiørboe E; Hoff-Lund O; Abildgaard M; Iversen K
    Ugeskr Laeger; 2012 Sep; 174(39):2286-9. PubMed ID: 23006221
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Injecting Alone: Practices and Preferences among People Who Inject Drugs in New York City.
    Riback L; Pérez-Correa AE; Ghiroli MM; López-Castro T; Fox AD
    Subst Use Misuse; 2022; 57(13):1988-1996. PubMed ID: 36151968
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intravenous fentanyl use among people who inject drugs in Australia.
    Geddes L; Iversen J; Memedovic S; Maher L
    Drug Alcohol Rev; 2018 Apr; 37 Suppl 1():S314-S322. PubMed ID: 29405465
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The potential public health and community impacts of safer injecting facilities: evidence from a cohort of injection drug users.
    Wood E; Kerr T; Spittal PM; Li K; Small W; Tyndall MW; Hogg RS; O'Shaughnessy MV; Schechter MT
    J Acquir Immune Defic Syndr; 2003 Jan; 32(1):2-8. PubMed ID: 12514408
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Controlled drug consumption rooms].
    Allilaire JF; Costentin J; Goullé JP; Hamon M; Laqueille X; Lejoyeux M; Mouren MC; Olié JP; Nordmann R; Tillement JP
    Bull Acad Natl Med; 2013 Feb; 197(2):503-5. PubMed ID: 24919375
    [No Abstract]   [Full Text] [Related]  

  • 27. A socio-structural approach to preventing injection drug use initiation: rationale for the PRIMER study.
    Werb D; Garfein R; Kerr T; Davidson P; Roux P; Jauffret-Roustide M; Auriacombe M; Small W; Strathdee SA
    Harm Reduct J; 2016 Sep; 13(1):25. PubMed ID: 27629248
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The implementation of overdose prevention sites as a novel and nimble response during an illegal drug overdose public health emergency.
    Wallace B; Pagan F; Pauly BB
    Int J Drug Policy; 2019 Apr; 66():64-72. PubMed ID: 30708237
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acceptability of supervised injection facilities among persons who inject drugs in upstate New York.
    Duncan E; Shufelt S; Barranco M; Udo T
    Harm Reduct J; 2022 Jul; 19(1):87. PubMed ID: 35907854
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Initial experience with subcutaneous depot buprenorphine in a medically supervised injecting facility.
    Weeks A; Cogger S; Clark N
    Drug Alcohol Rev; 2021 Nov; 40(7):1354-1355. PubMed ID: 33821545
    [No Abstract]   [Full Text] [Related]  

  • 31. Changing risk and presentation of overdose associated with consumption of street drugs at a supervised injection site in Vancouver, Canada.
    Notta D; Black B; Chu T; Joe R; Lysyshyn M
    Drug Alcohol Depend; 2019 Mar; 196():46-50. PubMed ID: 30665151
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The projected costs and benefits of a supervised injection facility in Seattle, WA, USA.
    Hood JE; Behrends CN; Irwin A; Schackman BR; Chan D; Hartfield K; Hess J; Banta-Green C; Whiteside L; Finegood B; Duchin J
    Int J Drug Policy; 2019 May; 67():9-18. PubMed ID: 30802842
    [TBL] [Abstract][Full Text] [Related]  

  • 33. My place, your place, or a safer place: the intention among Montréal injecting drug users to use supervised injecting facilities.
    Green TC; Hankins CA; Palmer D; Boivin JF; Platt R
    Can J Public Health; 2004; 95(2):110-4. PubMed ID: 15074900
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of drug consumption rooms on non-fatal overdoses, abscesses and emergency department visits in people who inject drugs in France: results from the COSINUS cohort.
    Roux P; Jauffret-Roustide M; Donadille C; Briand Madrid L; Denis C; Célérier I; Chauvin C; Hamelin N; Maradan G; Carrieri MP; Protopopescu C; Lalanne L; Auriacombe M;
    Int J Epidemiol; 2023 Apr; 52(2):562-576. PubMed ID: 35690956
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Examining Overdose and Homelessness as Predictors of Willingness to Use Supervised Injection Facilities by Services Provided Among Persons Who Inject Drugs.
    Kenney SR; Anderson BJ; Bailey GL; Herman DS; Conti MT; Stein MD
    Am J Addict; 2021 Jan; 30(1):21-25. PubMed ID: 32519449
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Science versus politics: the need for supervised injection facilities in Montreal, Canada.
    Jozaghi E
    Int J Drug Policy; 2012 Sep; 23(5):420-1. PubMed ID: 22818890
    [No Abstract]   [Full Text] [Related]  

  • 37. Willingness to utilize supervised injection facilities among people who inject drugs in Iran: Findings from 2020 national HIV bio-behavioral surveillance survey.
    Khezri M; Karamouzian M; Sharifi H; Ghalekhani N; Tavakoli F; Mehmandoost S; Mehrabi F; Pedarzadeh M; Nejat M; Noroozi A; Baral S; Shokoohi M
    Int J Drug Policy; 2021 Nov; 97():103355. PubMed ID: 34242959
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug consumption rooms in Catalonia: A comprehensive evaluation of social, health and harm reduction benefits.
    Folch C; Lorente N; Majó X; Parés-Badell O; Roca X; Brugal T; Roux P; Carrieri P; Colom J; Casabona J;
    Int J Drug Policy; 2018 Dec; 62():24-29. PubMed ID: 30352331
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The prevalence of non-fatal overdose among people who inject drugs: A multi-stage systematic review and meta-analysis.
    Colledge S; Peacock A; Leung J; Larney S; Grebely J; Hickman M; Cunningham E; Trickey A; Stone J; Vickerman P; Degenhardt L
    Int J Drug Policy; 2019 Nov; 73():172-184. PubMed ID: 31351755
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characteristics of persons who inject drugs and who witness opioid overdoses in Vietnam: a cross-sectional analysis to inform future overdose prevention programs.
    Blackburn NA; Lancaster KE; Ha TV; Latkin CA; Miller WC; Frangakis C; Chu VA; Sripaipan T; Quan VM; Minh NL; Vu PT; Go VF
    Harm Reduct J; 2017 Sep; 14(1):62. PubMed ID: 28882143
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.